• Reviva Pharmaceuticals (NASDAQ:RVPH) Upgraded by Roth Capital to "Strong-Buy" Rating

    Source: Buzz FX / 11 Jan 2025 04:56:14   America/Chicago


    Reviva Pharmaceuticals (NASDAQ:RVPH) Upgraded by Roth Capital to "Strong-Buy" Rating Written by MarketBeat January 11, 2025 Share Link copied to clipboard. Reviva Pharmaceuticals ( NASDAQ:RVPH - Get Free Report ) was upgraded by research an
    Read more...
Share on,